PATENT CLAIM ANALYSIS

Application Number: 16159550
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "450000"]

Abstract:
Systems and methods for producing liposomes, including control liposomes and immunoliposomes targeting breast cancer are provided. Systems and methods for treating breast cancer, using targeted immunoliposomes produced according to various methods are also disclosed herein. For example, trastuzumab-conjugated immunoliposomes may be used to deliver chemotherapeutic agents to breast cancer tissues for the treatment of breast cancer. Systems and methods for actuating liposomes using ultrasound are also disclosed, such as systems and methods for actuating trastuzumab-conjugated liposomes accumulated in breast cancer tissues for the treatment of breast cancer.

Claim (Index 2):
The method of  claim 1 , wherein the ultrasound applied to the treatment area comprises a low frequency ultrasound.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 97.0
- Lexical Diversity: 2.06522
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13912167', '14650355', '14832103', '13817054', '12400988']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7069321876779792
- 35 USC 102 Novelty (BERT): 0.5206429917696347
- Combined Prediction Score: 0.6883032680871447
- Mean Citation Score: 200.951194
- Max Citation Score: 223.86694
- Similarity Product: 110.92843019755183

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test